118 related articles for article (PubMed ID: 17929260)
21. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
[TBL] [Abstract][Full Text] [Related]
22. A mouse model of oral-esophageal carcinogenesis.
Opitz OG; Quante M; von Werder A; Heeg S; Blum HE
Onkologie; 2005 Jan; 28(1):44-8. PubMed ID: 15696643
[TBL] [Abstract][Full Text] [Related]
23. The significance of histological evidence of bile reflux gastropathy in patients with gastro-esophageal reflux disease.
Nakos A; Zezos P; Liratzopoulos N; Efraimidou E; Manolas K; Moschos J; Molivas E; Kouklakis G
Med Sci Monit; 2009 Jun; 15(6):CR313-8. PubMed ID: 19478703
[TBL] [Abstract][Full Text] [Related]
24. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury.
Souza RF; Huo X; Mittal V; Schuler CM; Carmack SW; Zhang HY; Zhang X; Yu C; Hormi-Carver K; Genta RM; Spechler SJ
Gastroenterology; 2009 Nov; 137(5):1776-84. PubMed ID: 19660463
[TBL] [Abstract][Full Text] [Related]
25. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Mulholland HG; Cantwell MM; Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; McGuigan J; Reynolds JV; Comber H; Murray LJ
Cancer Causes Control; 2009 Apr; 20(3):279-88. PubMed ID: 18839322
[TBL] [Abstract][Full Text] [Related]
26. Barrett's esophagus (BE) and carcinoma in the esophageal stump (ES) after esophagectomy with gastric pull-up in achalasia patients: a study based on 10 years follow-up.
da Rocha JR; Ribeiro U; Sallum RA; Szachnowicz S; Cecconello I
Ann Surg Oncol; 2008 Oct; 15(10):2903-9. PubMed ID: 18618179
[TBL] [Abstract][Full Text] [Related]
27. The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-kappaB activation in oesophageal cells, with a mechanism of action involving ROS.
Jenkins GJ; Cronin J; Alhamdani A; Rawat N; D'Souza F; Thomas T; Eltahir Z; Griffiths AP; Baxter JN
Mutagenesis; 2008 Sep; 23(5):399-405. PubMed ID: 18515815
[TBL] [Abstract][Full Text] [Related]
28. Role of bile reflux and Helicobacter pylori infection on inflammation of gastric remnant after distal gastrectomy.
Li XB; Lu H; Chen HM; Chen XY; Ge ZZ
J Dig Dis; 2008 Nov; 9(4):208-12. PubMed ID: 18959592
[TBL] [Abstract][Full Text] [Related]
29. The severity of duodeno-esophageal reflux influences the development of different histological types of esophageal cancer in a rat model.
Miyashita T; Miwa K; Fujimura T; Ninomiya I; Fushida S; Shah FA; Harmon JW; Hattori T; Ohta T
Int J Cancer; 2013 Apr; 132(7):1496-504. PubMed ID: 22961324
[TBL] [Abstract][Full Text] [Related]
30. Duodenal reflux produces hyperproliferative epithelial esophagitis--a possible precursor to esophageal adenocarcinoma in the rat.
Byrnes CK; Bahadursingh A; Akhter N; Parinandi NL; Natarajan V; Montgomery E; Tihan T; Duncan MD; Nass PH; Harmon JW
J Gastrointest Surg; 2003 Feb; 7(2):172-80. PubMed ID: 12600441
[TBL] [Abstract][Full Text] [Related]
31. Esophageal motility in patients with sliding hiatal hernia with reflux esophagitis.
Ye P; Li ZS; Xu GM; Zou DW; Xu XR; Lu RH
Chin Med J (Engl); 2008 May; 121(10):898-903. PubMed ID: 18706203
[TBL] [Abstract][Full Text] [Related]
32. Neither antioxidants nor COX-2 inhibition protect against esophageal inflammation in an experimental model of severe reflux.
Murphy JO; Ravi N; Byrne PJ; McDonald GS; Reynolds JV
J Surg Res; 2008 Mar; 145(1):33-40. PubMed ID: 17727884
[TBL] [Abstract][Full Text] [Related]
33. Epithelial cell hyperproliferation after biliopancreatic reflux into the esophagus of rats.
Pera M; Grande L; Gelabert M; Figueras X; Pera M; Palacín A; Elena M; Cardesa A; Tiburcio AF; Trastek VF
Ann Thorac Surg; 1998 Mar; 65(3):779-86. PubMed ID: 9527213
[TBL] [Abstract][Full Text] [Related]
34. Activation of MUC1 mucin expression by bile acids in human esophageal adenocarcinomatous cells and tissues is mediated by the phosphatidylinositol 3-kinase.
Mariette C; Piessen G; Leteurtre E; Hémon B; Triboulet JP; Van Seuningen I
Surgery; 2008 Jan; 143(1):58-71. PubMed ID: 18154934
[TBL] [Abstract][Full Text] [Related]
35. Neither antioxidants nor COX-2 inhibition protect against esophageal inflammation in an experimental model of severe reflux.
Murphy JO; Ravi N; Byrne PJ; McDonald GS; Reynolds JV
J Surg Res; 2007 Sep; 142(1):20-7. PubMed ID: 17543990
[TBL] [Abstract][Full Text] [Related]
36. Bile reflux esophagitis. A critical study of two models in the rat.
Salmon R; Hem B
Digestion; 1981; 22(2):73-9. PubMed ID: 7274608
[TBL] [Abstract][Full Text] [Related]
37. Bile and acid reflux in the pathogenesis of reflux oesophagitis in children.
Jiang M; Chen J; Chen F; Yu J; Liang J; Zhang Y; Ou B
J Paediatr Child Health; 2009; 45(1-2):64-7. PubMed ID: 19208069
[TBL] [Abstract][Full Text] [Related]
38. Specific induction of a 72-kDa heat shock protein protects esophageal mucosa from reflux esophagitis.
Izumi Y; Otaka M; Takahashi T; Takada M; Shimada Y; Asaoka D; Nagahara A; Itoh H; Watanabe S
Life Sci; 2009 Apr; 84(15-16):517-22. PubMed ID: 19302810
[TBL] [Abstract][Full Text] [Related]
39. Duodenogastroesophageal reflux: results of medical treatment and antireflux surgery.
Elhak NG; Mostafa M; Salah T; Haleem M
Hepatogastroenterology; 2008; 55(81):120-6. PubMed ID: 18507090
[TBL] [Abstract][Full Text] [Related]
40. [The effect of duodenal reflux on esophageal carcinogenesis in rats: preliminary report].
Segawa M; Miwa K; Miyazaki I; Hattori T
Nihon Geka Gakkai Zasshi; 1992 May; 93(5):562. PubMed ID: 1614404
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
